Liquid biomarkers for fibrotic NASH – progress in a complex field

Liquid biomarkers for fibrotic NASH – progress in a complex field

Bibliographic Details
Main Authors:	Myneni, S. (Author), Schuppan, D. (Author), Surabattula, R. (Author)
Format:	Article
Language:	English
Published:	Elsevier B.V. 2022
Subjects:	assay biological marker Biomarkers blood analysis Companion biomarker disease exacerbation Editorial fibrogenesis fibrosis Fibrosis human Humans liver biopsy liver fibrosis NAFLD nonalcoholic fatty liver Non-alcoholic Fatty Liver Disease prediction proteomics screening test serum marker
Online Access:	View Fulltext in Publisher

Similar Items

The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease
by: M A Livzan, et al.
Published: (2016-12-01)

Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease
by: José Tadeu Stefano, et al.
Published: (2021-01-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
by: Maria Del Ben, et al.
Published: (2018-02-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
by: Gwyneth Soon, et al.
Published: (2021-01-01)

Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
by: O M Drapkina, et al.
Published: (2016-02-01)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
by: Lucia Carulli, et al.
Published: (2019-02-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
by: Chan, W.-K, et al.
Published: (2022)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
by: Panyavee Pitisuttithum, et al.
Published: (2020-04-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Development of a non-invasive model to improve the accuracy of determining liver fibrosis stage in nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-11-01)

Liver function tests in identifying patients with liver disease
by: Ahmed Z, et al.
Published: (2018-08-01)

Diagnostic value of serum markers of fibrosis in chronic liver diseases
by: E V Vinnitskaia, et al.
Published: (2013-02-01)

NONALCOHOLIC FATTY LIVER DISEASE: COMORBIDITIES, CLINICAL SIGNIFICANCE AND EVALUATION OF LIVER FIBROSIS
by: D. V. Marshalko, et al.
Published: (2018-02-01)

Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)
by: Debashis Reja, et al.
Published: (2020-07-01)

Significant Burden of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Iranian Population: A Cross-Sectional Analysis
by: Behnam Hosseini Ahangar, et al.
Published: (2020-05-01)

A Positive Relationship between Betel Nut Chewing and Significant Liver Fibrosis in NAFLD Subjects, but Not in Non-NAFLD Ones
by: Yu-Tsung Chou, et al.
Published: (2021-03-01)

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
by: Umair Iqbal, et al.
Published: (2019-03-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Man-Hoon Han, et al.
Published: (2020-05-01)

Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population
by: Rommel Zambrano-Huailla, et al.
Published: (2020-11-01)

The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan
by: Lee YS, et al.
Published: (2021-03-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe
by: Grace Lai-Hung Wong, et al.
Published: (2013-07-01)

Liver Fibrosis: A Clinical Update
by: Lindsey C. Shipley, et al.
Published: (2019-05-01)

Biomarkers for liver fibrosis: Advances, advantages and disadvantages
by: A. Cequera, et al.
Published: (2014-07-01)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
by: Rui Yu, et al.
Published: (2018-04-01)

Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
by: Dae Ho Lee
Published: (2020-06-01)

Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)
by: J. C. Marín-Gabriel, et al.
Published: (2009-11-01)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
by: Seonghwan Hwang, et al.
Published: (2021-10-01)

Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance
by: Takuma Hasegawa, et al.
Published: (2020-05-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
by: Huang J, et al.
Published: (2021-02-01)

ATP citrate lyase inhibitor Bempedoic Acid alleviate long term HFD induced NASH through improvement in glycemic control, reduction of hepatic triglycerides & total cholesterol, modulation of inflammatory & fibrotic genes and improvement in NAS score
by: K.V. Sanjay, et al.
Published: (2021-01-01)

Comparative Transcriptomics Analyses in Livers of Mice, Humans, and Humanized Mice Define Human-Specific Gene Networks
by: Chengfei Jiang, et al.
Published: (2020-11-01)

Noninvasive diagnosis of pediatric nonalcoholic fatty liver disease
by: Hye Ran Yang
Published: (2013-02-01)

The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice
by: Earl Kim, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_pauf07su1f56vqum8ejutpd18n